Your browser doesn't support javascript.
loading
An IRF1-IRF4 Toggle-Switch Controls Tolerogenic and Immunogenic Transcriptional Programming in Human Langerhans Cells.
Davies, James; Vallejo, Andres F; Sirvent, Sofia; Porter, Gemma; Clayton, Kalum; Qumbelo, Yamkela; Stumpf, Patrick; West, Jonathan; Gray, Clive M; Chigorimbo-Murefu, Nyaradzo T L; MacArthur, Ben; Polak, Marta E.
Afiliação
  • Davies J; Clinical and Experimental Sciences, Sir Henry Wellcome Laboratories, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Vallejo AF; Clinical and Experimental Sciences, Sir Henry Wellcome Laboratories, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Sirvent S; Clinical and Experimental Sciences, Sir Henry Wellcome Laboratories, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Porter G; Clinical and Experimental Sciences, Sir Henry Wellcome Laboratories, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Clayton K; Clinical and Experimental Sciences, Sir Henry Wellcome Laboratories, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Qumbelo Y; Division of Immunology, Institute of Infectious Disease and Molecular Medicine, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Stumpf P; Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • West J; Institute for Life Sciences, University of Southampton, Southampton, United Kingdom.
  • Gray CM; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Chigorimbo-Murefu NTL; Institute for Life Sciences, University of Southampton, Southampton, United Kingdom.
  • MacArthur B; Division of Immunology, Institute of Infectious Disease and Molecular Medicine, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Polak ME; Division of Immunology, Institute of Infectious Disease and Molecular Medicine, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Front Immunol ; 12: 665312, 2021.
Article em En | MEDLINE | ID: mdl-34211464
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células de Langerhans / Fator de Necrose Tumoral alfa / Fatores Reguladores de Interferon Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células de Langerhans / Fator de Necrose Tumoral alfa / Fatores Reguladores de Interferon Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Suíça